Robles-Menchero MJ, Sánchez-Aranda A, Alonso-de Mendieta M, Carballo-Mondragón E, Molina-López JF, Kably-Ambe A

Language: Spanish
References: 20
Page: 204-211
PDF size: 201.43 Kb.

ABSTRACT

Objective: To determine the prevalence of Ureaplasma urealyticum and Mycoplasma hominis in couples with infertility that participated in a high complexity protocol for assisted reproductive techniques.
Materials and Methods: Observational longitudinal, retrospective and descriptive study in which pathogens from positive samples were collected from infertile couples during a high complexity protocol for assisted reproductive techniques in the Mexican Center for Fertility Dr. Alberto Kably Ambe (Hospital Ángeles Lomas) between 2016 and 2019.
Results: A total of 172 infertile couples participated in the study. As a protocol previous to the in vitro fertilization, culture was performed in women and men. Of the vaginal culture, 65.1% were reported positive and Ureaplasma urealyticum predominated on 52.9% of them. While 47.7% of the semen culture were positive, and Mycoplasma hominis was on 34.9% of them.
Conclusions: In infertile women, we reported a prevalence of 52.9% of Ureaplasma urealyticum and 15.1% of Mycoplasma hominis. For men, the proportion of positive cultures of Mycoplasma hominis was higher with 34.9%, while Ureaplasma urealyticum had a prevalence of 15.2%. Both microorganisms were present in the cultures of 5.8% of women and 7.6% of men.

REFERENCES

1. Piscopo R, Guimaraes R, Ueno J, Ikeda F, et al. Increased prevalence of endocervical Mycoplasma and Ureaplasma colonization in infertile women with tubal factor. JBRA Assisted Reproduction. 2020; 24 (2): 152-57. doi 10.5935/1518-0557.20190078.

2. Practice Committee of American Society for Reproductive Medicine. Definitions of infertility and recurrent pregnancy loss. Fertility and Sterility. 2013; 90 (1): 63. https://doi. org/10.1016/j.fertnstert.2012.09.023

3. Lindsay T, Vitrikas K. Evaluation and treatment of infertility. American Family Physician. 2015; 91 (5): 308-14.

4. Maroto MT, Romero B, Martínez L. Estudio del factor tuboperitoneal en la disfunción reproductiva. Hospital Unversitario Virgen de las Nieves, 2017. http://www.sefertilidad. net/docs/biblioteca/guiasPracticaClinicas/guia10.pdf.

5. Steyaert SR, Leroux-Roels GG, Dhont M. Infections in IVF: review and guidelines. Human Reproductive Update. 2000; 6: 432-41. https://doi.org/10.1093/humupd/6.5.432.

6. Ricci S, De Giorgi S, Lazzeri E, et al. Impact of asymptomatic genital tract infections on in vitro Fertilization (IVF) outcome. PLoS ONE. 2018; 13(11): 1-16. https://doi. org/10.1371/journal. pone.0207684.

7. D’Angelo A, Panayotidis C, et al. Recommendations for good practice in Ultrasound: Oocyte pick-up. Human Reproduction Open. 2019; 1-25. doi. 10.1093/hropen/hoz025.

8. Fernández M, García J, Pich O, Espasa M. Mycoplasma genitalium: un patógeno emergente en las consultas de ITS. Formación continuada en dermatología. 2020: 35(5): 301-311. doi. 10.1016/j.piel.2019.07.004.

9. Kelsey JL, Whittermore AS, Evans AS, et al. Methods in Observational Epidemiology. Vol 10. New York: Oxford University Press. 1996; 311-340. ISBN: 9780195083774.

10. Rodrigues MM, Fernandes PÁ, Haddad JP, et al. Frequency of Chlamydia trachomatis, Neisseria gonorrhoeae, Mycoplasma genitalium, Mycoplasma hominis and Ureaplasma species in cervical samples. Journal of Obstetrics and Gynaecology. 2011; 31(3):237-41. https://doi.org/10.310 9/01443615.2010.548880.

11. Seifoleslami M, Safari A, Khayyat M. Prevalence of Ureaplasma urealyticum and Mycoplasma hominis in High Vaginal Swab Samples of Infertile Females. Iranian Red Crescent Medical Journal. 2015; 17 (12): e16823. doi. 10.5812/ircmj.16823.

12. Milanezi F, Falconi A, Schnabel B, et al. Prevalence of Mycoplasma hominis and Ureaplasma spp. in Routine Gynecological Care in Sao Paulo City, Brazil. Archives of Clinical Infectious Diseases. 2016; 11(3): e36668. doi. 10.5812/ archcid.36668.

13. Zdrodowska-Stefanow B, Klosowska WM, Ostaszewska- Puchalska I, et al. Ureaplasma urealyticum and Mycoplasma hominis infection in women with urogenital diseases. Advances in Medical Science. 2006; 51: 250-253. PMID: 17357319.

14. Rodriguez R, Hernandez R, Fuster F, et al. Genital infection and infertility. Enfermedades Infecciosas y Micriobiología Clínica. 2001; 19(6):261-266. doi. 10.1016/s0213- 005x(01)72632-8.

15. Peerayeh SN, Samimi R. Detection of Ureaplasma urealyticum in clinical samples from infertile women by polymerase chain reaction. Iranian Journal of Pharmacology & Therapeutics. 2007; 6(1):23-26. doi. 1735-2657/07/61-23-26.

16. Leli C, Mencacci A, Bombaci JC, et al. Prevalence and antimicrobial susceptibility of Ureaplasma urealyticum and Mycoplasma hominis in a population of Italian and immigrant outpatients. Infez Med. 2012; 20 (2): 82-87. PMID: 22767305.

17. Hernández I, Aragón CI, Aldama PL, Jiménez J. Prevalence of infections (Chlamydia, Ureaplasma and Mycoplasma) in patients with altered tuboperitoneal factor. Ginecología y Obstetricia de México. 2016; 84 (1): 14-18. PMID: 27290842.

18. Sleha R, Boštíková V, Hampl R, et al. Prevalence of Mycoplasma hominis and Ureaplasma urealyticum in women undergoing an initial infertility evaluation. Epidemiol Mikrobiol Imunol. 2016; 65(4):232-237. PMID: 28078900.

19. García C, Liébana C, Gutiérrez B, et al. Prevalencia en varones de la población general de agentes productores de infecciones no ulcerativas del aparato genital, asistidos en atención especializada. Revista Española de Quimioterapia. 2019; 32 (6): 545-50. PMID: 31642639.

20. Góngora A, González C, Parra L. Estudio retrospectivo en el diagnóstico de Mycoplasma y Ureaplasma en muestra seminal de 89 pacientes en la Ciudad de México. Revista de la Facultad de Medicina. 2015; 58 (1): 1-12.